Back to top

Tale of the Tape

Myriad Genetics, Inc. Enters Oversold Territory
February 08, 2013


Trades from $3

Myriad Genetics, Inc.’s (MYGN - Analyst Report) share price has entered into oversold territory with a stochastic value of 17.8110. The Zacks Consensus Estimate on the company’s earnings for year ending June 2013 increased by 4 cents over the past week to $1.58 per share. Myriad Genetics, Inc. is a Zacks Rank #1 (“Strong Buy”) company.